2016年2月23日星期二

Prof. Xia Yuting, Former President of ShenYang Military General Hospital Spoke Highly of FUDA for Performing Over 10,000 Cases of Cryosurgery and Being the First to Have Performed NanoKnife Therapy in Mainland of China

On November 2015, Xia Yuting, a nationally renowned digestive disease expert, former Vice President of Shenyang Military General Hospital paid a visit to Guangzhou Fuda Hospital, during which he spoke highly of FUDA for “taking a lead in technology for cancer and bringing benefit to people around the world”. The meeting was also attended by Xu Kecheng, Chief President of Fuda Cancer Hospital, Zuo Jiansheng, the CEO of Guangzhou Fuda Medical Investment Management Limited Liability Company, Liu Jianguo, General Manager of Guangzhou Fuda Medical Investment Management Limited Liability Company, and Prof. Niu Lizhi, Executive President of Guangzhou Fuda Cancer Hospital.
 
A photo of Zuo Jiansheng (L1), Xia Yuting (L2) and Xu Kecheng (L3) et al. 
Prof. Xia Yuting was graduated from Jilin University of Medical Science (current Norman Bethune University of Medical Science) in 1963. He was the former Vice President and head of Medical Administration Department of ShenYang Military General Hospital with the title of senior colonel. At present, he serves as the expert of Evaluation Center of Drug Pricing National Development and Reform Commission, expert of National Medical Malpractice Identification Committee, and adviser of China Society of Digestive Endoscopy. He is also a doctoral supervisor and chief physician.


Prof. Xia Yuting stayed at Fuda Cancer Hospital for three hours, during which he personally experienced the hospital environment, visited the medical facilities, and conversed with medical workers. After General Liu Jianguo introduced the hospital, Prof. Xia Yuting emotionally said, “We are here to study the way you run a hospital. One of my accompanying friends also wants to establish a hospital. I told him that firstly he should establish a specialized hospital; secondly, he should established a hospital for advanced cancer patient; thirdly, he should learn from Prof. Xu Kecheng.
 
He said that he once paid a visit to the hospital that Prof. Xu Kecheng established in Shekou, Shenzhen. Compared to that hospital, the current Fuda Cancer Hospital is a much better “upgraded version” of the old one. Prof. Xia Yuting said, “It takes courage to establish a private hospital in the first place” when he recalled that Prof. Xu Kecheng quit his secure job in public hospital and established a private hospital.
 
When he learned that Fuda Cancer Hospital has been committing itself to commonwealth undertakings and donated over 10 million RMB after Wenchuan and Yushu earthquakes, he said, “I used to believe that a hospital cannot seek development without fund, but my way of thought is totally changed after I visited FUDA and learned the status quo of FUDA. I realized that the perspective on money itself is important, but money is not a prerequisite for running a hospital. What strike me the most is the special spirit that Fuda Cancer Hospital has presented.” 
He said, “Xu Kecheng and I have been friends for over 30 years. I come here to visit my old pal and witness with my own eyes the achievement that FUDA has made. I believe that Prof. Xu Kecheng has been leading the development of the hospital under the guidance of CPC. The fact that he has been committing himself to the development of the hospital and to the commonwealth undertakings is not just a spur of the moment. Thanks to his political orientation, he has been devoting himself to servicing the people with advanced medical science and technology over the past 30 years and more. I am firmly convinced that to treat patient with excellent medical skill is the political orientation of all medial workers. Prof. Xu Kecheng has done what a medical worker is supposed to do.”
 
In recent years, Chief President Xu Kecheng has won many honors, such as “Role Model of the Times”, “Award Nomination of the 5th National Moral Models” and etc. Prof. Xia Yuting said, “after I learned all the honors that Prof. Xu has earned in recent years, I would like to say he has been leading a tough life over the past few years.” he further added, “there has been discussion going on in the field of digestive disease community that Xu Kecheng has made a great fortune in recent years. But I want to say that he has become all the more wealthy physically and spiritually with his excellent skill and noble morality. I admire him for the unrivaled spiritual wealth he has earned.”
 
Executive President Niu Lizhi introduced that medical workers at FUDA performed that first NanoKnife therapy for pancreatic cancer patient in Mainland of China on July 1. The number of NanoKnife therapy cases that FUDA has performed accounts for over 50% in Mainland of China.
 
Prof. Xia Yuting summarized that Fuda has carried out over ten thousand cases of cryosurgery and has been leading the way in the field of NanoKnife therapy in China. He said, FUDA has been seeking development with excellent skills and bringing well-being to patients with noble morality”. He further added that quality service alone is not enough to attract patients. It is with a down-to-earth manner and advanced medical technology that FUDA has treated many patients with good curative effects. Medical workers at FUDA have carried out more than 10,000 cases of cryosurgery, which ranks the first in Asia. Moreover, FUDA has performed the most cases of NanoKnife therapy in China since the introduction of NanoKnife system. FUDA is also focusing its attention on biotherapy. He said, “FUDA has always been committing itself to applying high-grade, high-precision and advanced technology into medical practice, which has treated patient from all over the world.”
General Manager Liu Jianguo stated that “there is an Indonesian patient who has been to our hospital for over 40 times within 8 years. Over 60%  of our patients have been to FUDA for more than one time. They would never come back if we do not have advanced technology.”
 
Prof. Xia Yuting further added, “the development direction of Fuda Cancer Hospital is in conformity with the route of current medical reform dominated by the government. It’s not hard to see a doctor in China, at least in a second-class hospital. But most of patients are not willing to seek treatment in a second-class hospital but a famous one. Why common people are not willing to seek treatment in second-class hospitals? I found the answer after I paid a visit to Fuda Cancer Hospital. The main reasons are that some second-class hospitals don’t have advanced technology while some don’t have quality service that can attract patients. The recipe behind FUDA’s success lies in its core medical technology, quality service and outstanding management.” 
 
In the end, he summarized that Fuda Cancer Hospital has been taking a lead in technology for cancer and bringing benefit to people across the world.
 

2016年2月20日星期六

The First Nano Knife (irreversible electroporation) Treatment for Cancer in Mainland of China Completed in Guangzhou

In the morning of July 1, 2015, a special operation was undergoing in the operation room of Guangzhou Fuda Cancer Hospital. The patient lying on the operation table was a 61-year-old man from Middle East. With the assistance of renowned abdominal surgeon--Prof. Li Chaolong, Dr. Niu Lizhi cut open the patient’s upper abdominal with adept skill, separated stomach and intestinal canal to expose pancreas. A 4.5x5.0cm large quasi circular mass is found. Dr. Niu put the ultrasonic surgical probe on the mass and an uneven high- density echo displayed on the ultrasound screen. Under the guidance of ultrasound image, Dr. Niu placed a special electrode needle (called main needle) into one side of the mass and inserted its tip to the bottom of the mass; then two auxiliary electrode needles were inserted into the other side and the center of the mass separately. The three needles formed a tripod shape with the distance between each standing at 2cm.

Beside the operating table, an engineer was adjusting the medical equipment called “NanoKnife.” On the screen displayed flashing electric pulse, which meant that the equipment was at operational readiness. Beneath the NanoKnife was a special electrocardiogram equipment, which displayed the patient’s cardiac rhythm.

The treatment started. Dr. Niu ordered: electric shock. According to the premeditated plan, three groups of electric shocks with 1500V voltage and 70 microseconds pulse length are administered with 90 pulses in each group. With the pulses pushing in, the ultrasound screen displayed that the original high-density echo of the tumor was getting lower.

After the above-mentioned procedures were done, Dr. Niu changed the position of two auxiliary electrode needles and electric pulses were administered again. Then, three electrode needles were pulled up and electric pulses were administered again. After repeating the process for five times, the tumor had fully received electric pulses. The CT scan (contrast agent enhancement) on the second day showed whole tumor necrosis.

This is a memorable moment. On this day, FUDA succeed in treating pancreatic cancer by adopting the world’s latest ablation technology--irreversible electroporation for the first time in Guangzhou, also in China. The technology got its name “Nano Knife” because it would make nanoscale membrane perforation in targeted tissue or cells.

As a significant progress in tumor treatment of the 21st century, tumor ablation has presented an effective treatment and even radical chance for patients with unresectable tumor or patients who cannot tolerate operation. The most frequently used technologies include thermal ablation (radio-frequency and microray) and cryoablation (Argon-Helium Knife and liquid nitrogen). Nano Knife is a special ablation technology belonging to neither thermal ablation nor cryoablation. If ablation could be compared to the “crown “of local treatment for cancer, then Nano Knife could be compared to the “pearl” on the “crown”. The basic rationale of Nano Knife is that ablation probes release microsecond high voltage pulse that breaks tumor cell membrane so as to form nanoscale irreversible electroporation and finally kill targeted cells (cancer cells).

A series of experiments and clinical research indicate that compared with other ablation technologies, Nano Knife has the following unique advantages: the ablation of tissue is selective. The ablation destroys only cells and does no harm to vascular wall, nerve, trachea, bronchus, gallbladder, intestinal canal, and ureter; boundaries of ablation area is clear, which is extremely important for small volume pancreas; ablation does not generate energy nor rely on it, and it is not influenced by the blood flow of adjacent big vessels, such as celiac artery and aorta; the death of cells is not necrosis but apoptosis, which could stimulate anticancer immune responses; the ablation requires short treatment time. It just takes 5 minutes to ablate 3.0 cm large tumor and anesthesia time will also shorten accordingly, which is conducive to postoperative recovery. The ablation process can be clearly displayed on ultrasound, CT or MR, thus ensuring the maximal effect of ablation.

Developed and manufactured by America AngiDymanics company, Nano Knife was approved by America FDA for “soft tissue tumor ablation”, which was hailed by experts around the world. European Union, Australia, Canada has also successively approved Nano Knife for application. As of today, over 100 key tumor hospitals have adopted this technology in treating more than 6,000 cases. Treated tumors are located in pancreas, lungs, kidney, prostate, and other parenchymal organs as well as in soft tissues. It is especially applicable to tumors near big vessels, hepatic hilum, gallbladder, bile ducts, and ureter. According to literature, Nano Knife is of great value in treating pancreatic cancer.

Nano Knife can not only be applied to surgery, such as laparotomy. Electrodes needles can also be inserted into tumor through puncture point and percutaneous ablation can be administered under the guidance of CT or ultrasound. In recent days, under the guidance of CT and ultrasound, doctors in FUDA have carried out percutaneous Nano Knife ablation on a postoperative gastric cancer metastasis and a pancreatic head tumor.

In June, 2015, China approved Nano Knife for tumor treatment. In order to apply Nano Knife into clinical treatment in an early date, one year before it is approved by China, Dr. Niu Lizhi has led experts and relevant medical workers to study stacks of literature and arranged several study tours in America. They compiled the first monograph about Nano Knife in China, New Technique of Cancer Ablation: Irreversible Electroporation published by Shanghai Science and Technology Literature in 2014. In cooperation with overseas institutions, experts and medical workers in FUDA carried out a large number of Nano Knife ablation experiments on animals, studied its influence and safety on such key structures as nerves, vessels, bile ducts and ureter and published the first paper about Nano Knife in China on  Journal of Interventional Radiology.

During operation
Nano Knife electrode needles
Before Treatment
After Treatment


2016年2月18日星期四

Guangzhou Fuda Cancer Hospital Held Media Promotion Conference on NanoKnife Therapy (New Treatment for Cancer)

Media promotion conference on NanoKnife Therapy for cancer was held in the conference room of Guangzhou Fuda Cancer Hospital, October 27, 2015. Chief President Xu Kecheng, the founder of Fuda together with General Manager Liu Jianguo and President Niu Lizhi attended the conference and made special report. Over a dozen of media including China News Service, Nanfang Daily, Yangcheng Evening News, Guangzhou Daily, Information Times, Southern Metropolis Daily, News Express, Guangdong TV and Guangzhou TV attended the conference and make special coverage.

Liu Jianguo, General Manager of Fuda Cancer Hospital is delivering a keynote speech
The media promotion conference started with the keynoted speech--Walk Into Fuda and Learn About FUDA--delivered by Liu Jianguo, General Manager of Guangzhou Fuda Cancer Hospital. He introduced to friends from media the development concept, development history, featured technology and services, medical team & personnel development and scientific research progress of FUDA with a focus on the introduction of FUDA’s cultural construction and charity activities.


Media Friends
Prof. Xu Kecheng, the Chief President of Guangzhou Fuda Cancer Hospital, as well as a cancer survivor, shared his anti-cancer experience with the participants. He emphasized,“ As we are running a cancer hospital, we have been placing patient in the first place, fully committed to scientific innovations with the aim of providing the best medical technologies for our patient. Though death is inevitable, we can prolong patient’s lifespan, improve their quality of life, and render an easier life for them with our featured technology. NanoKnife therapy (IRE) is another fine example of scientific and technological innovation.”


It is reported that the Nanoknife system is a nonthermal and novel minimally-invasive technology for tumor ablation. It is also known as Irreversible Electroporation (IRE). Its rationale goes like as follows: during the procedure, high electric-field and ultrashort pulses are given to destroy lipid bilayer structure of cancer cell membrane and form numerous irreversible nano-sized pores in the cell membrane. Cell membrane permeability will be changed to allow molecules of different sizes free access to cells, which will lead to cell death. As it causes no heat island effect, it inflicts no incomplete treatment or thermal injury. Tumor cells besides blood vessels can also be completely eliminated.IRE is formally approved by China for clinical application in June 2015. Guangzhou Fuda Cancer Hospital became the first in Mainland of China to introduce NanoKnife system. On July 2, the medical team led by Dr. Niu Lizhi performed the first NanoKnife therapy for pancreatic cancer, which has delivered remarkable curative effects. Under the leadership of Niu Lizhi, medical team at FUDA has carried out NanoKnife therapy for over 40 cancer patient, all of which have produced remarkable curative effects.
President Niu is introducing NanoKnife therapy
On the conference, Niu Lizhi pointed out that NanoKnife therapy for cancer falls into the category of minimally invasive treatment and inflicts no injuries to such tissue structures as blood vessels, bile duct and nerves adjacent to tumor. Electrode of 1mm in diameter is inserted into tumor percutaneously and then computer technology calculates and predicts the location and size of electric field. Electrodes releases high electricity and ultrashort pulses to form strong electric field and make numerous irreversible nano-sized pores in the cell membrane, which will lead to cell death. After treatment, human body will activate healing response, absorb apoptotic cell and replace tumor with new cells.

A 61-year-old man from middle east, Prof. Pratibha Rajgopal from India and Ms. Wang, a former hostess of Hubei TV station all suffered from pancreatic cancer and received NanoKnife therapy at FUDA. The procedure went well with short operative time. Patients had good postoperative recovery and achieved remarkable curative effects.


Patient representative is making a speech
At present, NanoKnife therapy has made remarkable achievement in the field of pancreatic cancer treatment. Niu Lizhi said pancreatic cancer is a highly malignant digestive tract tumor with high mortality. The reason behind the high mortality is that 80% pancreatic cancer patients have local progression or metastases upon diagnosis, thus the tumor is unresectable and not responding well to chemotherapy and radiotherapy. As IRE is free from the influence of ambient temperature, it can effectively ablate tissues surrounding great vessels, limit damage to extracellular matrix and protect great vessels and bile duct structure. Therefore, IRE is the best treatment for pancreatic cancer that is adjacent to such lumen as portal vein, deep vein, and common bile duct.

Media friends are making an interview with President Niu Lizhi



2016年2月16日星期二

Launching Ceremony of Guangdong Provincial Light of Life Society of Cancer Rehabilitation in conjunction with Forum on Green Rehabilitation of Cancer

On the morning of December 6, 2014, the launching ceremony of Guangdong Provincial Light of Life Society of Cancer Rehabilitation, the first mass organization in Guangdong Province that cancer patients have been looking up to for 22 years and Forum on Green Rehabilitation of Cancer were held on the Langham Place Guangzhou. 

Ms. Zhang Wenxiang, Former Deputy Director of Propaganda Department of the CPC Central Committee; Academician Fang Daiming, Vice President of Chinese Academy of Engineering; Mr. Geng Qingshan, CPC Party Secretary of Guangdong Provincial People’s Hospital; Ms. Shi Anli, President of Chinese Cancer Rehabilitation Society; Mr. Liang Jian, Standing Vice President of Guangdong Branch Redcross Society of China; Ms. Gan Ping, Secretary General of Guangdong Branch Redcross Society of China; Ms. Tang Jie, Director of Guangdong Provincial Health Education Center; Professor Dong Baowei from Chinese PLA General Hospital and Tsinghua University; Professor Tan Dongfeng and Karen Basen Enquist from the University of Texas MD Anderson Cancer Center; Professor Chen Guangyao from Veterans General Hospital, representatives of charitable organizations, media friends and members of Light of Life Society merrily gathered to celebrate this grand event.
 

The venue of Guangdong Provincial Light of Life Society of Cancer Rehabilitation Launching Ceremony and
Forum on Green Rehabilitation of Cancer

At 9 o’clock in the morning, Cantonese song “Dream Back to Taihu” raised the curtain, followed by a video presentation of Light of Life Society and congratulatory messages from Vice Governor Lin Shaochun of Guangdong Province, Vice President Yao Zhibin of Guangdong Provincial People's Political Consultative Conference and President Yin Dakui of Chinese Medical Doctor Association. Former Deputy Director Zhang Wenxiang of Propaganda Department of the CPC Central Committee, Standing Vice President Liang Jian of Guangdong Branch Redcross Society of China and President Shi Anli of Chinese Cancer Rehabilitation Society made addresses successively. President Xu Kecheng of Guangdong Provincial Light of Life Society of Cancer Rehabilitation, reviewing distress and joy that Light of Life Society has experienced on the way to help thousands of cancer patients and expressing thanks for great support of government and society.
 

Cantonese song “Dream Back to Taihu”
   
Address oration of (L1) Deputy Director Zhang Wenxiang, (L2) Vice President Liang Jian, (R2) President Shi Anli, (R1) President Xu Kecheng

 
Afterwards, President Xu Kecheng awarded letters of appointment to the honorary presidents of Light of Life Society that include financially strong entrepreneurs, medical experts and scholars to thank for their great assistances and supports in the development of the society.
 
The unveiling ceremony impelled the conference to its climax. Guided by ritual girls, Deputy Director Zhang Wenxiang, President Xu Kecheng, Vice President Liang Jian and President Shi Anli walked onto the stage and unveiled the curtain along with the music and applauses, declaring a new development stage of the Light of Life Society.
 

President Xu Kecheng (L1), Deputy Director Zhang Wenxiang (L2), President Shi Anli (R2) and
Vice President Liang Jian (R1) unveiling the curtain

During the conference, cancer survivors’ wonderful performance won the audience’s acclaim, demonstrating their optimistic attitude to fight cancer.
The Forum on Green Rehabilitation of Cancer began after the opening ceremony ended. Experts from China, America and European countries gave presentations on cancer prevention, treatment and rehabilitation. Professor Karen Basen Engquist from the University of Texas MD Anderson Cancer Center shared the experience in cancer prevention and rehabilitation, whilst Professor Chen Guangyao from Taiwan delivered a speech on "cancer screening and prevention measures", focusing on experience sharing. Professor Qiao Youlin from Department of Cancer Institute & Epidemiology of Chinese Peking Union Medical College of Chinese Academy of Medical Sciences shared the research progress of epidemiology and prevention of cancer in China. President Shi Anli of Chinese Cancer Rehabilitation Society introduced the current status, existing problems and developing direction of overall cancer rehabilitation in China. Academician Fan Daiming from the Chinese Academy of Engineering was the last speaker who made a report on the nature of cancer. He believes that the key molecular event (CAKMEs) in tumor evolution is a core clinical problem.
 

(L)Professor Karen Basen Engquist;(M)Professor Chen Guangyao;(R)Professor Qiao Youlin

 (L)President Shi Anli; (R)Academician Fan Daiming
 
With the support from government and society, Guangdong Provincial Light of Life Society of Cancer Rehabilitation, a domestic and overseas mass organization that cancer patients have been looking up to for 22 years is officially registered and established. Before being officially registered, the Light of Life Society went through trials and hardship for 22 years. The opening ceremony today is a new beginning of the organization. The mission of Guangdong Provincial Light of Life Society of Cancer Rehabilitation is to utilize scientific method and knowledge to lead all members in cancer prevention and rehabilitation in terms of life style, nutrition, exercise, mentality and immunity. Light of Life also aims to popularize knowledge about cancer, establish and improve cancer rehabilitation networks and create positive energy for improving and maintaining health.

2016年2月15日星期一

Xu Kecheng Winning Award Nomination of the 5th National Moral Models on October 13, 2015

Winner list of the 5th National Moral Model was revealed on October 13, 2015. Xu Kecheng, the Chief President of Guangzhou Fuda Cancer Hospital won the award nomination of National Moral Model.


The symposium on the 5th National Moral Model was held in Beijing that afternoon. President Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee and chairman of the CPC Central Military Commission made important instructions and expressed his warm congratulations and lofty respect to commended national moral models. Liu Yunshan, member of the Standing Committee of the Political Bureau of the CPC Central Committee and Director of Central Civilization Office attended the symposium and read President Xi Jinping’s important instructions. Liu Yandong, member of the Standing Committee of the Political Bureau of the CPC Central Committee and Vice Governor of State Council also attended the symposium.


The appraisal activity of the 5th National Moral Model was launched in April. 62 people won National Moral Model award and 265 won award nomination of National Moral Model award.


Chief President Xu Kecheng attended the symposium in the afternoon and award gala in the evening.